Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Psychiatry

Sec. Adolescent and Young Adult Psychiatry

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1657837

Treatment-Refractory Catatonia in an Adolescent with a de novo SIK1 Candidate Variant: A Case Report of a Multidisciplinary Diagnostic Odyssey

Provisionally accepted
Emmanuelle  HodaraEmmanuelle Hodara1,2*Alexis  SeeganAlexis Seegan3Jianling  JiJianling Ji2,4Alexander  Van SpeybroeckAlexander Van Speybroeck2,4
  • 1Keck School of Medicine, University of Southern California, Los Angeles, United States
  • 2Children's Hospital Los Angeles, Los Angeles, United States
  • 3University of California Irvine, Irvine, United States
  • 4University of Southern California Keck School of Medicine, Los Angeles, United States

The final, formatted version of the article will be published soon.

We report the case of an adolescent patient who developed severe, treatment-refractory catatonia with progressive neurological decline over five years following a brief, self-limited acute psychotic episode following a prodromal period emerging at age 11 with disorganized behavior and restricted, stereotyped interests. Her atypical presentation marked by prolonged mutism, function loss, and retrograde amnesia, unresponsive to standard therapies, showed dramatic improvement with a combination of memantine, oxcarbazepine, and electroconvulsive therapy (ECT). Trio-clinical exome sequencing revealed a de novo likely pathogenic variant in the SIK1 gene, highlighting the utility of genomic diagnostics in complex neuropsychiatric presentations and emphasizing the ongoing need for multidisciplinary collaboration and advocacy in patient care.

Keywords: Catatonia, Treatment-refractory, Electroconvulsive therapy (ECT), genetic work-up, SIK1 Candidate Variant, case report

Received: 01 Jul 2025; Accepted: 29 Aug 2025.

Copyright: © 2025 Hodara, Seegan, Ji and Van Speybroeck. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Emmanuelle Hodara, Keck School of Medicine, University of Southern California, Los Angeles, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.